Clinical trial
Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates…
NCT00461396 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00461396 |
|---|---|
| Title | Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron |
| Official title | Open-Label, Multicenter, Observational, Phase IV Study to Evaluate the Adherence to Treatment With 250mcg (8MIU) IFNB-1b (Betaseron®) Given Subcutaneous Every Other Day Over a Period of up to 12 Months in Patients With a First Clinical Demyelinating Event Suggestive of Multiple Sclerosis and… |
| Acronym | START |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis, Relapsing-Remitting |
| Intervention type | Drug |
| Interventions | Interferon-1beta (Betaseron, BAY86-5046) |
| Enrollment | 104 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Apr 18, 2007 |
| Last update posted | Apr 8, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: